Literature DB >> 12182869

Synthesis and evaluation of 4-hydroxyphenylacetic acid amides and 4-hydroxycinnamamides as antioxidants.

Young-Sik Jung1, Tae-Souk Kang, Joong-Ho Yoon, Bo-Young Joe, Hee-Jong Lim, Churl-Min Seong, Woo-Kyu Park, Jae-Yang Kong, Jungsook Cho, No-Sang Park.   

Abstract

4-Hydroxyphenylacetic acid amides and 4-hydroxycinnamamides were synthesized and their antioxidant and neuroprotective activities were evaluated. Among the prepared compounds, 8b, and exhibited potent inhibition of lipid peroxidation in rat brain homogenates, and marked DPPH radical scavenging activities. Furthermore, and exhibited neuroprotective action against the oxidative damage induced by the exposure of primary cultured rat cortical cells to H(2)O(2), xanthine/xanthine oxidase, or Fe(2+)/ascorbic acid. Based on these results, we found that was the most potent antioxidant among the compounds tested.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12182869     DOI: 10.1016/s0960-894x(02)00479-1

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  In silico development, validation and comparison of predictive QSAR models for lipid peroxidation inhibitory activity of cinnamic acid and caffeic acid derivatives using multiple chemometric and cheminformatics tools.

Authors:  Indrani Mitra; Achintya Saha; Kunal Roy
Journal:  J Mol Model       Date:  2012-03-21       Impact factor: 1.810

2.  Hesperidin as a preventive resistance agent in MCF-7 breast cancer cells line resistance to doxorubicin.

Authors:  Rifki Febriansah; Dyaningtyas Dewi Pamungkas Putri; Nunuk Aries Nurulita; Edy Meiyanto; Agung Endro Nugroho
Journal:  Asian Pac J Trop Biomed       Date:  2014-03

3.  Synthesis of caffeic acid sulfonamide derivatives and their protective effect against H2O2 induced oxidative damage in A549 cells.

Authors:  Xiaoyu Peng; Tingjun Hu; Yuxue Zhang; Anran Zhao; Bharathi Natarajan; Jiata Wei; Hao Yan; Hailan Chen; Cuiwu Lin
Journal:  RSC Adv       Date:  2020-03-09       Impact factor: 4.036

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.